Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.33 USD | +4.67% | +8.49% | -35.46% |
Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- Analyst Reco.